Study of Foretinib in Combination With Lapatinib in Patients With Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Foretinib|DRUG: Lapatinib
Sponsor: NCIC Clinical Trials Group
Collaborators: GlaxoSmithKline